Literature DB >> 2389908

Small airway dimensions in smokers with obstruction to airflow.

C H Bosken1, B R Wiggs, P D Paré, J C Hogg.   

Abstract

The obstruction to airflow that develops in some cigarette smokers is thought to be related to inflammation of small airways. However, the mechanism by which inflammation leads to obstruction has not been elucidated. We performed morphometry to determine if the airways of patients with obstruction were thicker than normal. Sixty smokers were selected from those undergoing resectional lung surgery. They were grouped according to their FEV1/FVC ratio (FEV1% control = 77%, FEV1 obstructed = 55%) and matched for age, sex, and height. Wall area (mm2), perimeter (mm), and diameter (mm) were measured by a modification of the technique of James and coworkers (7). The relaxed luminal diameter (mm) and wall thickness (mm) were calculated from these values. A pathology score for inflammation and fibrosis was assigned to each patient, and the percentage of the wall made up of muscle, epithelium, and connective tissue was determined by point counting. Two hundred airways, 90% of which were membranous bronchioles, were measured in each group. The mean-measured luminal diameter in the controls was 0.81 mm and in the obstructed patients 0.70 mm (p less than or equal to 0.05). The regression lines relating wall thickness to calculated luminal diameter showed that the airways of the obstructed patients were thicker throughout the size range measured (p less than or equal to 0.005). The muscle, epithelium, and connective tissue were all increased in the obstructed patients (p less than or equal to 0.001). In addition, the wall thickness correlated with the pathology score (r = 0.6074, p less than or equal to 0.002).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2389908     DOI: 10.1164/ajrccm/142.3.563

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  43 in total

1.  Main bronchial diameters in patients with very severe COPD.

Authors:  Gaëlle Mourissoux; Christophe Vandendries; Hélène Neveu; Antoine Scherrer; Marc Fischler
Journal:  J Anesth       Date:  2010-03-26       Impact factor: 2.078

2.  Assessment of a new transtelephonic portable spirometer.

Authors:  S Abboud; I Bruderman
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

3.  The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.

Authors:  A G Jarnicki; H Schilter; G Liu; K Wheeldon; A-T Essilfie; J S Foot; T T Yow; W Jarolimek; P M Hansbro
Journal:  Br J Pharmacol       Date:  2016-10-12       Impact factor: 8.739

4.  Effects of inhalation of N-formyl-methionyl-leucyl-phenylalanine in the well elderly and in patients with chronic bronchitis.

Authors:  M J Peters; A B Breslin; N Berend
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

5.  Relation between distal airspace size, bronchiolar attachments, and lung function.

Authors:  D Lamb; A McLean; M Gillooly; P M Warren; G A Gould; W MacNee
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

Review 6.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Transforming growth factor beta 1 gene expression in human airways.

Authors:  J D Aubert; B I Dalal; T R Bai; C R Roberts; S Hayashi; J C Hogg
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

8.  Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype.

Authors:  Tonio Pera; Reinoud Gosens; Andries H Lesterhuis; Riham Sami; Marco van der Toorn; Johan Zaagsma; Herman Meurs
Journal:  Respir Res       Date:  2010-04-29

Review 9.  Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?

Authors:  Annelies Slats; Christian Taube
Journal:  Ther Adv Respir Dis       Date:  2015-11-22       Impact factor: 4.031

Review 10.  Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.

Authors:  Kazutetsu Aoshiba; Atsushi Nagai
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.